Publicaciones en las que colabora con MARÍA ÁNGELES MORO SÁNCHEZ (177)

2024

  1. Myeloid cells in vascular dementia and Alzheimer's disease: Possible therapeutic targets?

    British Journal of Pharmacology, Vol. 181, Núm. 6, pp. 777-798

  2. The role of gut microbiota in cerebrovascular disease and related dementia

    British Journal of Pharmacology, Vol. 181, Núm. 6, pp. 816-839

2023

  1. Comparison of 2 medium cutoff dialyzers versus on-line hemodiafiltration regarding depurative ability and albumin loss: An uncontrolled clinical research

    Artificial Organs, Vol. 47, Núm. 3, pp. 589-594

  2. Defective hippocampal neurogenesis underlies cognitive impairment by carotid stenosis-induced cerebral hypoperfusion in mice

    Frontiers in Cellular Neuroscience, Vol. 17

  3. Ipsilesional Hippocampal GABA Is Elevated and Correlates With Cognitive Impairment and Maladaptive Neurogenesis After Cortical Stroke in Mice

    Stroke, Vol. 54, Núm. 10, pp. 2652-2665

  4. Safety and Efficacy of ApTOLL in Patients with Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial

    JAMA Neurology, Vol. 80, Núm. 8, pp. 779-788

  5. Saturated fatty acid-enriched small extracellular vesicles mediate a crosstalk inducing liver inflammation and hepatocyte insulin resistance

    JHEP Reports, Vol. 5, Núm. 8

2022

  1. Cav-1 Protein Levels in Serum and Infarcted Brain Correlate with Hemorrhagic Volume in a Mouse Model of Thromboembolic Stroke, Independently of rt-PA Administration

    Molecular Neurobiology, Vol. 59, Núm. 2, pp. 1320-1332

  2. Del laboratorio a la clínica en el ictus isquémico agudo. Modelos experimentales in vitro e in vivo

    Revista de neurologia, Vol. 75, Núm. 9, pp. 283-293

  3. Diurnal Differences in Immune Response in Brain, Blood and Spleen After Focal Cerebral Ischemia in Mice

    Stroke, Vol. 53, Núm. 12, pp. E507-E511

  4. Endothelial cells regulate astrocyte to neural progenitor cell trans-differentiation in a mouse model of stroke

    Nature Communications, Vol. 13, Núm. 1

  5. Fingolimod Does Not Reduce Infarction After Focal Cerebral Ischemia in Mice During Active or Inactive Circadian Phases

    Stroke, Vol. 53, Núm. 12, pp. 3741-3750

  6. First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers

    Molecular Therapy - Nucleic Acids, Vol. 28, pp. 124-135

  7. Neutrophil Extracellular Trap Targeting Protects Against Ischemic Damage After Fibrin-Rich Thrombotic Stroke Despite Non-Reperfusion

    Frontiers in Immunology, Vol. 13

  8. The neurovascular unit and systemic biology in stroke — implications for translation and treatment

    Nature Reviews Neurology, Vol. 18, Núm. 10, pp. 597-612

2021

  1. Circadian Biology and Stroke

    Stroke, Vol. 52, Núm. 6, pp. 2180-2190

  2. Effective glutamate clearance from the systemic circulation by hemodialysis: Potential relevance for cerebral ischemia management

    Artificial Organs, Vol. 45, Núm. 10, pp. 1183-1188

  3. Influence of metabolic syndrome on post-stroke outcome, angiogenesis and vascular function in old rats determined by dynamic contrast enhanced MRI

    Journal of Cerebral Blood Flow and Metabolism, Vol. 41, Núm. 7, pp. 1692-1706

  4. Pathophysiological and pharmacological relevance of TLR4 in peripheral immune cells after stroke

    Pharmacology and Therapeutics, Vol. 228

  5. Role of TLR4 in Neutrophil Dynamics and Functions: Contribution to Stroke Pathophysiology

    Frontiers in Immunology, Vol. 12